Interventional oncology turns profit for rad groups
Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Dr. Catherine Tuite and colleagues at the University of Pennsylvania reviewed data from 68 patients who underwent radiofrequency ablation of liver tumors at Penn's outpatient interventional radiology clinic from 1999 to 2003. They recorded all aspects involved with the management of interventional oncology patients, including initial consultation, diagnostic imaging, intervention, and follow-up.
The relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively. The average revenue to the radiology practice totaled more than $120,000 annually, coauthor Dr. Michael C. Soulen said at the meeting of the Society of Interventional Radiology in April.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
